Advice for Mid-Size Biopharma on Biomanufacturing Challenges and Strategies for Success

April 6, 2017

Stephen Lam, Senior Vice President, Patheon, talks with BioPharm International about two of the top challenges facing biopharma today ─ demand forecasting and capacity availability ─ and how to leverage flexibility to ensure a successful biomanufacturing strategy.

Spotlight

Cambridge Regulatory Services

Regulatory Affairs Specialists with clients ranging from start-up biotechs to multinational pharmaceutical companies. Cambridge Regulatory Services has expertise and.

OTHER VIDEOS

Digital Health solutions for patient centric clinical trials

video | August 24, 2021

Digital health solutions for remote patient data collection and continuous patient monitoring are enabling us to reduce patient burden and accelerate our clinical trials. Halsey Lea, Director Data Science, Data Science & AI, R&D, explains the transformative role that digital connected devices are playing in our smart clinical trial programmes....

Watch Now

EMBL researchers identifying how potential drugs work in the fight against COVID-19

video | April 16, 2020

EMBL researchers are studying how drugs that have shown good results against COVID-19 work in living cells. This will help them to quickly identify other drugs that could treat the disease, which are urgently needed until a vaccine is developed, and possibly afterwards as well....

Watch Now

Why the War on Drugs is a War on People

video | April 14, 2020

The War on Drugs was launched in the United States by former President Richard Nixon in 1971. This allowed for the criminalization of drug use, which led to the mass incarceration of millions of Americans, particularly for communities of color....

Watch Now

Hydroxychloroquine's false hope: How an obscure drug became a coronavirus cure

video | April 13, 2020

Claims about hydroxychloroquine and chloroquine have taken hold of the global consciousness. Online conversations, media articles and politicians’ statements quickly - and incorrectly - labeled it as a ‘cure’ for covid-19, the disease caused by the novel coronavirus....

Watch Now

Spotlight

Cambridge Regulatory Services

Regulatory Affairs Specialists with clients ranging from start-up biotechs to multinational pharmaceutical companies. Cambridge Regulatory Services has expertise and.

Events